THE NICKLES GROUP, LLC for CSL BEHRING LLC
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
H.R. 5376, the Build Back Better Act, as it relates to the orphan drug credit, corporate and international taxes.
Foreign entity interest: CSL Limited, identified on Registration (LD-1), has an interest in activities of its U.S. subsidiary CSL Behring LLC on all issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RACHEL JONES HENSLER | — |
Health Issues HCR
Monitored issues related to the medical supply chain.
Foreign entity interest: CSL Limited, identified on Registration (LD-1), has an interest in activities of its U.S. subsidiary CSL Behring LLC on all issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREG D'ANGELO | — |
| MARY BETH SAVARY TAYLOR | — |
Medicare/Medicaid MMM
Issues related to home infusion and plasma therapies. Monitored issues related to value based payment arrangements. Drug pricing issues related to H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act, H.R. 5376, The Build Back Better Act, and H.R. 19/S. 2164, the Lower Costs, More Cures Act. H.R. 5376, The Build Back Better Act, as it relates to plasma derived products and drug pricing.
Foreign entity interest: CSL Limited, identified on Registration (LD-1), has an interest in activities of its U.S. subsidiary CSL Behring LLC on all issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREG D'ANGELO | — |
| MARY BETH SAVARY TAYLOR | — |
Government Issues GOV
Issues related to plasma and plasma therapies. Monitored drug pricing issues related to H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act and H.R. 19, the Lower Costs, More Cures Act. H.R. 3684 (P.L. 117-58), The Infrastructure Investment and Jobs Act, as it relates to drug pricing. Issues involving promoting plasma donation. H.R. 5376, The Build Back Better Act, as it relates to drug pricing.
Foreign entity interest: CSL Limited, identified on Registration (LD-1), has an interest in activities of its U.S. subsidiary CSL Behring LLC on all issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRETT BAKER | — |
Budget/Appropriations BUD
Monitored S.Con.Res. 14, FY 2022 Budget Resolution.
Foreign entity interest: CSL Limited, identified on Registration (LD-1), has an interest in activities of its U.S. subsidiary CSL Behring LLC on all issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREG D'ANGELO | — |
| RACHEL JONES HENSLER | — |
| MARY BETH SAVARY TAYLOR | — |
Homeland Security HOM
Issues related to access to plasma and plasma therapies.
Foreign entity interest: CSL Limited, identified on Registration (LD-1), has an interest in activities of its U.S. subsidiary CSL Behring LLC on all issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DONALD KENT | — |
| MARY BETH SAVARY TAYLOR | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.